AU2002331279A1 - Pharmaceutical composition for treating hypercholesterolaemia - Google Patents

Pharmaceutical composition for treating hypercholesterolaemia

Info

Publication number
AU2002331279A1
AU2002331279A1 AU2002331279A AU2002331279A AU2002331279A1 AU 2002331279 A1 AU2002331279 A1 AU 2002331279A1 AU 2002331279 A AU2002331279 A AU 2002331279A AU 2002331279 A AU2002331279 A AU 2002331279A AU 2002331279 A1 AU2002331279 A1 AU 2002331279A1
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
hypercholesterolaemia
treating
treating hypercholesterolaemia
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002331279A
Inventor
Erich Elstner
Jobst Krauskopf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
S K Enterprise GmbH
Original Assignee
S K Enterprise GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S K Enterprise GmbH filed Critical S K Enterprise GmbH
Publication of AU2002331279A1 publication Critical patent/AU2002331279A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AU2002331279A 2001-07-20 2002-07-22 Pharmaceutical composition for treating hypercholesterolaemia Abandoned AU2002331279A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10135493A DE10135493A1 (en) 2001-07-20 2001-07-20 New use of calcium compounds, e.g. calcium L-lactate, for treating hypercholesterolemia and associated diseases such as coronary heart disease
DE10135493.2 2001-07-20
PCT/EP2002/008154 WO2003011309A2 (en) 2001-07-20 2002-07-22 Pharmaceutical composition for treating hypercholesterolaemia

Publications (1)

Publication Number Publication Date
AU2002331279A1 true AU2002331279A1 (en) 2003-02-17

Family

ID=7692564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002331279A Abandoned AU2002331279A1 (en) 2001-07-20 2002-07-22 Pharmaceutical composition for treating hypercholesterolaemia

Country Status (4)

Country Link
EP (1) EP1408992A2 (en)
AU (1) AU2002331279A1 (en)
DE (1) DE10135493A1 (en)
WO (1) WO2003011309A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10233229A1 (en) * 2002-07-22 2004-02-12 S.K. Enterprise Gmbh Pharmaceutical composition for lowering triglyceride levels
DE10331202A1 (en) 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Use of whey permeate for the treatment of metabolic syndrome
DE102006036285A1 (en) 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Whey permeate fractions and their use for the prevention and treatment of type 2 diabetes and metabolic syndrome
CA3087953A1 (en) 2018-01-12 2019-07-18 Metimedi Pharmaceuticals Co., Ltd. Methods of treating chronic inflammatory diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1808173B2 (en) * 1967-11-15 1976-03-18 Nadrol-Chemie-Pharma Keizer KG, 4500 Osnabrück CALCIUM OROTATE
JPS63198630A (en) * 1987-02-13 1988-08-17 Kao Corp Lipid metabolism improver
US5126150A (en) * 1990-10-01 1992-06-30 The Procter & Gamble Company Compositions containing psyllium
JPH04148651A (en) * 1990-10-12 1992-05-21 Norihiro Kamata "konjak" enriched with iron and calcium
JPH05304928A (en) * 1992-04-29 1993-11-19 Aroma Kagaku Kikai Kogyo:Kk Production of food containing calcium
JPH1014534A (en) * 1996-06-27 1998-01-20 Snow Brand Milk Prod Co Ltd Nutritive composition
CN1167581A (en) * 1997-07-09 1997-12-17 张永新 Nutrient calcium milk oatmeal
US6403129B1 (en) * 1999-12-27 2002-06-11 Mac Farms, Inc. Carbonated fortified milk-based beverage and method of making carbonated fortified milk-based beverage for the supplementation of essential nutrients in the human diet
CN1259384A (en) * 1999-01-06 2000-07-12 哈尔滨红太阳实业有限公司 Bone strengthening powder made of yak marrow and its processing method
GB9900339D0 (en) * 1999-01-09 1999-02-24 Zeneca Ltd Chemical compounds
CN1245021A (en) * 1999-07-29 2000-02-23 王操 Milk tea with VA, VD and calcium lactate
HU226640B1 (en) * 1999-10-18 2009-05-28 Egis Gyogyszergyar Nyilvanosan Process for producing amorphous atorvastatin calcium salt
CN1282536A (en) * 2000-08-29 2001-02-07 刘国柱 Formula of nutritive carrot-gingko beverage and its preparing process

Also Published As

Publication number Publication date
EP1408992A2 (en) 2004-04-21
DE10135493A1 (en) 2003-01-30
WO2003011309A2 (en) 2003-02-13
WO2003011309A3 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
AU2002313236A1 (en) Medicinal compositions
AU2002342613A1 (en) Treatment for wounds
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
AU2002302147A1 (en) Pharmaceutical composition
AU2001266338A1 (en) Pharmaceutical compositions for angiogenic therapy
AU2002257582A1 (en) Pharmaceutical formulation
AU2002258221A1 (en) Medicinal composition
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2001274877A1 (en) Pest treatment composition
AU2002252981A1 (en) Pharmaceutical compositions containing beta-mimetic agents and having few side-effects
AU4085201A (en) Pharmaceutical composition
AU2002337713A1 (en) Pharmaceutical compositions and methods for treating cancer
AU2002331279A1 (en) Pharmaceutical composition for treating hypercholesterolaemia
AU2002354460A1 (en) Medicinal composition
AU4698900A (en) Pharmaceutical compositions for treating malaria
AU2001278705A1 (en) Pharmaceutical composition
AU3586401A (en) Pharmaceutical composition
AUPR529701A0 (en) Pharmaceutical composition
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease
AU2002353915A1 (en) Methods and compositions for treating rotavirus-mediated disease
AU2002346223A1 (en) Medicinal compositions
AU2003252701A1 (en) Medicinal composition for treating thrombopenia
AU2002320937A1 (en) Pharmaceutical preparation for treating wounds
AU2002250845A1 (en) Pharmaceutical composition for treating multiple sclerosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase